![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Visby Medical’s COVID-19 Rapid Test Gets Expanded EUA
Visby Medical’s COVID-19 Rapid Test Gets Expanded EUA
![Visby medical - COVID-19 test](https://www.fdanews.com/ext/resources/test/Device_Images6/Visby-medical-covid-19-test.gif?t=1613079185&width=430)
February 12, 2021
The FDA has approved an expanded Emergency Use Authorization (EUA) for Visby Medical’s rapid polymerase chain reaction (PCR) COVID-19 test.
The new EUA allows the palm-sized test to be used by any organization that has a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver. That means it can be used directly at the point-of-care.
Visby said that its rapid PCR test requires only a power plug and uses no additional instrument or reader to return results.
Upcoming Events
-
21Oct